Skip to main content
. 2013 Dec 9;124(1):367–384. doi: 10.1172/JCI63146

Figure 11. Analysis of previously published microarray dataset of samples from 295 breast cancer patients.

Figure 11

(AD) Kaplan-Meier survival analysis of 295 breast cancers (45) classified as having high, medium, or low expression of PFKP, GFPT1, GFPT2, either together (A) or singly (BD). P values were calculated using log-rank test.